SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-023577
Filing Date
2023-03-28
Accepted
2023-03-28 13:40:37
Documents
15
Period of Report
2023-03-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea175909-8k_inmedpharma.htm   iXBRL 8-K 39038
2 NEWS RELEASE, DATED MARCH 28, 2023 ea175909ex99-1_inmedpharma.htm EX-99.1 14837
7 GRAPHIC ex99-1_001.jpg GRAPHIC 15956
  Complete submission text file 0001213900-23-023577.txt   297729

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inm-20230328.xsd EX-101.SCH 3470
4 XBRL DEFINITION FILE inm-20230328_def.xml EX-101.DEF 26195
5 XBRL LABEL FILE inm-20230328_lab.xml EX-101.LAB 35952
6 XBRL PRESENTATION FILE inm-20230328_pre.xml EX-101.PRE 24853
9 EXTRACTED XBRL INSTANCE DOCUMENT ea175909-8k_inmedpharma_htm.xml XML 4312
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 23768204
SIC: 2834 Pharmaceutical Preparations